Solutions

Biopharma workflows for valuation, evidence, and scientific analysis.

Each page below maps a real ARiDA capability surface to the decisions it supports, the workflows it can run, the data sources it touches, and the artifacts it leaves behind.

Capability map

Start from the business decision, then inspect the workflow.

These solution surfaces are grounded in the current workflow, tool, and sandbox inventory.

01

Valuation

Biotech Valuation

ARiDA runs evidence-backed biotech valuation workflows across single assets, multi-asset portfolios, platforms, fundraises, real options, Monte Carlo risk, and board dossiers.

A valuation workspace for teams that need assumptions, evidence, model outputs, and board language to stay connected.

Open solution
02

Advanced valuation

Advanced Valuation

Defend probability of success and valuation assumptions by tracing target biology, comparator trials, biomarkers, patents, sponsor history, market context, and evidence strength.

A valuation reasoning page for teams that need to explain why the PoS and value assumptions are defensible, not just calculate an rNPV.

Open solution
03

ROA

Real Options Analysis

Quantify the value of strategic flexibility in biotech R&D with binomial lattices, Longstaff-Schwartz Monte Carlo, compound options, Greeks, exercise boundaries, and option-value decomposition.

A decision model for assets where the option to wait, expand, abandon, stage, or pivot is part of the value.

Open solution
04

Portfolio

Portfolio Optimization

Prioritize and defend a biopharma portfolio with value modeling, correlation, downside risk, stage-gate logic, scenarios, and board-ready recommendations.

A portfolio decision layer for teams choosing what to accelerate, hold, partner, kill, or fund next.

Open solution
05

Competitive intelligence

Competitive Intelligence

Build competitive landscapes, TPP comparisons, patent-cliff views, market-share scenarios, and response plans from live web, trial, patent, literature, and database evidence.

A competitive intelligence workspace where each evidence lane stays inspectable before it becomes a narrative.

Open solution
06

Clinical trials

Clinical Trial Intelligence

Analyze trial landscapes, protocol patterns, endpoints, enrollment signals, sponsor behavior, recent registry changes, and historical AACT structure.

A trial intelligence layer for questions where registry structure, recency, endpoints, and protocol details matter.

Open solution
07

Literature

Systematic Review

Run PRISMA-style biomedical literature reviews with PubMed and PMC search lanes, screening logic, evidence tables, certainty summaries, and durable review artifacts.

A literature review workflow that makes the evidence table the product backbone.

Open solution
08

Patents

Patent Landscape

Map biotech patent families, assignees, citations, jurisdictions, claims, and whitespace using EPO, Google Patents data, web extraction, and structured IP workflows.

An IP evidence lane that connects patent families and assignee behavior to strategy, diligence, and competitive timing.

Open solution
09

Sandbox

Sandbox Analysis

Use natural language to run custom Python, statistics, forecasting, machine learning, optimization, visualization, ETL and mini-app analyses inside an isolated biopharma workspace.

A custom analysis surface for biotech decisions that need more than a fixed dashboard or pre-built calculator.

Open solution
10

Data analysis

Biomedical Data Analysis

Analyze biomedical files, tables, model outputs, and database extracts with Python, SQL, statistics, machine learning workflows, and durable artifacts.

A coding and analytics workspace for teams that need reproducible tables, models, charts, files, and conclusions in the same thread.

Open solution
11

Scientific analysis

Cheminformatics and Structure

Analyze compounds, fingerprints, scaffolds, ADMET-style properties, molecular similarity, protein structures, contacts, B-factors, SASA, and sequence or structure evidence.

Scientific analysis workflows for molecular, compound, sequence, and structure questions that need code-backed artifacts.

Open solution
12

Strategy

Indication Expansion

Scan, assess, and sequence indication opportunities with scientific rationale, clinical feasibility, competitive density, IP context, market structure, and valuation logic.

A decision program for choosing where an asset or platform should go next, with the evidence and economics visible.

Open solution
51
valuation tools

Specialized tools for rNPV, rpNPV, ROA, platform value, BD deals, Monte Carlo risk, and reporting.

121
skills on disk

Workflow and analysis instructions spanning financial, life-science, data-science, literature, patent, strategy, and document work.

330+
sandbox packages

A packed E2B environment for scientific Python, SQL, ML, documents, visualization, bio/chem, OCR, and browser automation.